Concepedia

Feng Ren

FR

Statistics

Publications

58

Citations

2.5K

H-Index

26

Active since

1993

Affiliations

GlaxoSmithKline (China)(Current)

Insilicos (United States)

Hong Kong Science and Technology Parks Corporation

Buck Institute for Research on Aging

Kyoto Institute of Technology

Feng Ren is an author at GlaxoSmithKline (China) specializing in drug discovery, medicinal chemistry, and pharmacology.

ORCID

Publications per year

1993–2025

58

Publications

58

AlphaFold accelerates artificial intelligence powered drug discovery: efficient discovery of a novel CDK20 small molecule inhibitor

Feng Ren, Xiao Ding, Min Zheng et al. · Chemical Science · 2023 · 326 citations · Full text

, , +8

A small-molecule TNIK inhibitor targets fibrosis in preclinical and clinical models

Feng Ren, Alex Aliper, Jian Chen et al. · Nature Biotechnology · 2024 · 270 citations · Full text

, , +17

Chemistry42: An AI-Driven Platform for Molecular Design and Optimization

Yan A. Ivanenkov, Daniil Polykovskiy, Dmitry S. Bezrukov et al. · Journal of Chemical Information and Modeling · 2023 · 197 citations · Full text

, , +17

PandaOmics: An AI-Driven Platform for Therapeutic Target and Biomarker Discovery

Petrina Kamya, Ivan V. Ozerov, Frank W. Pun et al. · Journal of Chemical Information and Modeling · 2024 · 126 citations · Full text

, , +17

Identification of Therapeutic Targets for Amyotrophic Lateral Sclerosis Using PandaOmics – An AI-Enabled Biological Target Discovery Platform

Frank W. Pun, Bonnie Hei Man Liu, Xi Long et al. · Frontiers in Aging Neuroscience · 2022 · 99 citations · Full text

, , +17

1–5 of 58